|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
|
|||
 |
 |
The Welch Foundation Award in Chemistry
for 2007 RESPONSE NEEDED BY Friday, January 5, 2007 The Welch Award in Chemistry encourages basic chemical research, recognizing chemical research contributions to the benefit of mankind. Faculty who have made important contributions in chemical research and have not been similarly rewarded are eligible. This one-time award in the amount of $300,000 will be presented at a special dinner in honor of the recipient. Details for the Award Program can be found at: http://www.welch1.org/Awards/ Once again this year, Hopkins has been invited to submit one nomination for this award. Therefore, an internal peer review will be managed through the Provost's Office. Required materials for internal review:
Please submit nomination materials no later than Friday, January 5, 2007, via email, to graceb@jhu.edu. This ensures that the internal selection can be completed in a timely fashion and the final nomination can be submitted to the Welch Foundation by February 1, 2007. If you have any questions, please contact Grace Bigelow (graceb@jhu.edu) or visit: http://jhuresearch.jhu.edu/funding.htm#jhu-coordinated.
RESPONSE NEEDED BY Monday, January 8, 2007 The Doris Duke Clinical Scientist Development Award Program supports junior faculty with an M.D. or M.D. /Ph.D. (physician-scientists) early in their careers as independent clinical researchers. This program is designed to assist physician-scientists in making the conversion from trainees to independent clinical investigators. Junior-level faculty working in any disease area will be considered. The Foundation strongly encourages women and under-represented minorities in medicine to apply for this award. The Clinical Scientist Development Award provides $135,000 per year for 3 years. Hopkins may submit three nominations for this special award program, and the internal peer review to select nominees will be managed through the Provost's Office. Required materials for internal review:
Full program information and specific requirements can be obtained on the DDCF Clinical Scientist Development Award Program website located at: http://www.ddcf.org/page.asp?pageId=291. Interested candidates should submit a complete packet of materials for internal review no later than 5 p.m. on Monday, January 8, 2007, via email, to graceb@jhu.edu. This ensures that the internal selection can be completed in a timely fashion and the final proposals can be submitted to the DDCF by the March 6, 2007 deadline. If you have any questions, please contact Grace
Bigelow (graceb@jhu.edu) or visit
the University Research Projects Administration website: http://jhuresearch.jhu.edu/
Funding is available to support multidisciplinary
research in prostate cancer through the Patrick C. Walsh Prostate Cancer
Research Fund. Awards of $50,000 to $100,000 for up to 2 years are available
to fund career development and developmental research programs (pilot
projects). New Ideas Encouraged!
RESPONSE NEEDED BY Monday, January 15, 2007 The Ellison New Scholar Award in Aging Program was established to support new investigators showing outstanding promise in basic biological sciences research (including biology, biomedicine and epidemiology) to understand aging processes and age-related diseases and disabilities. This award will support new and creative research unlikely to be funded by traditional sources. The award will fund up to $50k per year for four years. Selected nominees must be within the first three years of a full time faculty appointment (tenure or non-tenure) in the sponsoring institution, having been appointed no later than March 1, 2007 and no earlier than July 15, 2004. Program details can be obtained on the Ellison website located at: http://www.ellisonfoundation.org/adsp.jsp?key=nsa_over&show=110 Once again this year, Hopkins has been invited to submit one nomination for this award. Therefore, an internal peer review will be managed through the Provost's Office. Required materials for internal review: Please submit application materials no later than Monday, January 15, 2007, via email, to graceb@jhu.edu. This ensures that the internal selection can be completed in a timely fashion and the final nomination can be submitted to the Ellison Medical Foundation by Thursday, March 1, 2007. If you have any questions, please contact Grace Bigelow (graceb@jhu.edu) or visit: http://jhuresearch.jhu.edu/funding.htm#jhu-coordinated.
Deadline: January 18, 2007 Howard Hughes Medical Institute is pleased to announce a national competition for the appointment of outstanding physician-scientists as HHMI investigators. This focused competition reflects the Institute's longstanding interest in supporting physician-scientists who connect the insights gained through interaction with patients to rigorous programs of laboratory research that generate new approaches to the treatment of human disease. HHMI wishes to appoint approximately 15 new investigators who lead patient-oriented research programs and whose scientific work is influenced by their interaction with patients. This patient-oriented competition differs from all previous competitions in two crucial ways. HHMI will place no restrictions on the number of applications from any of the 121 eligible institutions. Second, researchers with faculty appointments will apply directly; prior institutional approval will not be required. Those candidates with outstanding records who have shown evidence of significant originality and productivity are encouraged to apply. HHMI welcomes applications from outstanding women and minorities underrepresented in the sciences. More information on this competition can be found
here: http://www.hhmi.org/ Please Note: An internal review of applications by the Provost's Office is not required for this program. Before submitting directly to the sponsor, proposals must be first submitted through the candidates' divisional research administration office. Additionally, a copy of the finalized application should be sent to Grace Bigelow via email at graceb@jhu.edu.
Deadline: March 1, 2007 (Preliminary Application) The Leukemia & Lymphoma Society's Translational
Research Program was established to encourage and provide support for
new and novel clinical research. The goal of the program is to accelerate
transfer of findings from the laboratory to clinical application. The
program's purpose is to fund research that shows high promise for translating
basic biomedical knowledge to prevention or new treatments and, ultimately,
to prolong and enhance life.
Technical developments in the rapidly advancing fields of genomics, proteomics, metabolomics, and imaging are transforming how patients and physicians evaluate risk, prevention, detection, and the treatment of cancer. These emerging technologies will lead to rapid, cost-effective, and coordinated evaluation of an individual's DNA sequence, complex patterns of RNA and protein expression, and metabolic regulation. This in turn, presents exciting opportunities to translate such knowledge into clinical management. Canary Foundation, in partnership with the American Cancer Society, is extending its postdoctoral fellowship program focused on studies in the tools and technologies for developing strategies for the early detection of cancer. Research should be directed at new approaches to improve clinical methods for the screening of primary tumors and/or metastases, including, but not limited to research focused in the following areas:
Most of the projects that will be funded are expected to have a direct impact on the early detection of cancer. However, research designed to provide the conceptual or experimental foundation for the future development of methods for early detection will also be considered. Studies such as those examining the psychosocial barriers that prevent individuals or groups taking advantage of existing methods for the early detection of cancer will not be considered at this time. The review and ranking of applications will be based on: the achievements and promise of the applicant; the feasibility and innovation of the research plan; and the scientific environment provided by the mentor. Applicants are required to submit a letter of intent by January 16th, 2007 briefly describing the project and mentor. Only those applications that are judged to be appropriate responses to the RFA will be permitted to submit an application. Projects not considered appropriate for this RFA can be evaluated with all other postdoctoral applications received for the subsequent April 1 ACS deadline. Awards will be 3 years in duration with progressive stipends of $42,000, $44,000, and $46,000 per year, plus $4,000 per year for institutional allowance. Based upon the availability of funds and the scientific merit of the applications, it is anticipated that up to 3 awards will be made. To restrict funding to full 3 year fellowships, applications will only be accepted from scientists who, at the time of application, have had no more than 2 years of research experience beyond their terminal degree (MD or PhD). Applicants must be US citizens or permanent residents working with an accomplished mentor at a non-profit institution. Awardees will be asked to attend the "Realizing the Promise" Early Detection Symposium May 22-24, 2007. Deadlines: Letter of intent: January 16, 2007. Complete application: February 20, 2007. For additional information regarding program policies, instructions for submission of the letter of intent, or to obtain an application, please refer to the ACS website: www.cancer.org/research. To learn about the Canary Foundation, please visit www.canaryfoundation.org. For specific inquiries, please contact:
|
 |
|
||||||
|
|
|
|
|
JHM Appointments | Employment @ JHM | Finding a Doctor | FAQs | Disclaimer | Maps & Directions | Contact JHM | Site Map |
|
|
